Xuelei Li

Xuelei Li

Auto-generated profile, based on publicly available information

Xuelei Li

School of Nursing, Bengbu Medical University, Longzi District, Bengbu, 233000, China, 86 18005529759

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2025 in Patient Preference and Adherence
Verified
Journal Article
Open access
PDF file
GZGuoli Zhang
Guoli Zhang
YXYuxin Xia
Yuxin Xia
XLXuelei Li
Xuelei Li
YZYun Zhang
Yun Zhang
XXXuejie Xu
Xuejie Xu
HXHui Xie
Hui Xie
Background: Despite proven benefits, intelligent personalized exercise prescription (IPEP) adherence remains low in middle-aged and older adults with chronic diseases (MOACD). Research evidence suggests that mobile health (mHealth)-based gamification interventions can improve participation in physical activity; however, their effects on adherence to IPEP remain unclear. Moreover, most studies report that adherence often declines rapidly once gamification interventions end, and no effective strategies have been proposed to address this issue. This study embeds the Octalysis gamification framework into a smartphone-based app to investigate the effects of an mHealth-based gamification intervention on adherence to IPEP among MOACD, as well as on related physical and psychological outcomes. Additionally, the study examines whether combining gamification interventions with health education can help sustain adherence after the intervention concludes. Methods: We propose a double-center, single-blind, three-arm randomized controlled trial. We will recruit 132 MOACD who will participate in dyads (66 pairs). Participants will be randomly assigned to three groups: a non-gamification group, a gamification group, or a health education plus gamification group. The intervention will last for 12 weeks, followed by a 12-week follow-up period. The primary outcome is adherence to IPEP, defined as the proportion of days on which participants completed their prescribed exercise tasks at 12 and 24 weeks. Secondary outcomes include biomedical risk factors, sedentary behavior, sleep quality, self-efficacy, intrinsic motivation, patient satisfaction, and the acceptability of the intervention. Conclusion: This trial employs the Octalysis gamification framework to design an intervention aimed at enhancing adherence to the IPEP. The findings may inform the development of scalable digital interventions to promote physical activity and long-term adherence among MOACD.

22 July 2025 in JMIR Preprints
Verified
Preprint
Open access
GZGuoli Zhang
Guoli Zhang
YMYibo Meng
Yibo Meng
JWJiayuan Wang
Jiayuan Wang
YXYuxin Xia
Yuxin Xia
YZYun Zhang
Yun Zhang
TSTing Sun
Ting Sun
BACKGROUND While research on using gamification interventions to promote physical activity (PA) is increasing, related reviews remain at the descriptive level of intervention effects and element usage, lacking a systematic analysis of motivational mechanisms. It is difficult to support a motivation-oriented intervention design, thereby limiting the potential of gamification in stimulating users’ intrinsic motivation and maintaining long-term behavior change. OBJECTIVE This systematic review aims to systematically identify and analyze the motivational mechanisms that promote PA in mobile health (mHealth) gamification interventions, and attempts to construct a structured design framework from a motivation-driven perspective to support more targeted intervention development. METHODS This study searches for English literature published between January 2010 and October 2024 in five databases: PubMed, Web of Science, Embase, Scopus, and SPORTDiscus (EBSCOhost). Original empirical studies assessing the impact of gamification interventions on PA were included. Two researchers independently conducted a mapping of motivational mechanisms for the gamification interventions included in the study according to the definitions of the eight core drives in the Octalysis framework. Subsequently, thematic analysis was used to code and cluster the mapping results, in order to extract representative types of gamification design and further analyze their adaptability within specific populations. RESULTS A total of 67 studies were included. Mapping the motivational mechanisms revealed that most interventions (53/67, 79.1%) activated two or three core drives, with Development and Accomplishment, Social Influence and Relatedness, and Loss and Avoidance being the most frequently triggered. Through coding and clustering the mapping results, we extracted 20 representative gamification design types. The preliminary adaptability analysis suggested that certain design types (such as the social support type and the level maintenance reward type) were more suitable for older adults or patients with chronic conditions, while others (such as the virtual mission type and the game progress-driven type) were better aligned with the preferences of children and adolescents who are more exploratory and drawn to immersive virtual contexts. CONCLUSIONS This study develops a three-dimensional design framework of “core drives-gamification design types-suitable populations,” which can offer theoretical references for future personalized and motivation-oriented gamification intervention designs. CLINICALTRIAL (registration number: CRD42025638455)

30 June 2026 in JMIR Serious Games
Verified
Journal Article
Open access
YZYun Zhang
Yun Zhang
XLXueLei Li
XueLei Li
GZGuoLi Zhang
GuoLi Zhang
HZHaiYin Zhang
HaiYin Zhang
YXYuXin Xia
YuXin Xia
TSTing Sun
Ting Sun
Background: As a neurodegenerative disorder, Parkinson disease (PD) demonstrates significant prevalence worldwide. As the population ages, the number of patients with PD increases. Individuals with PD are susceptible to varying degrees of cognitive and psychological impairments. Virtual reality (VR)–based therapy is an emerging technology used for cognitive recovery and mental health treatment, yet controversy remains. Objective: This study aimed to assess the impact of VR-based therapies on cognitive function and depression in patients with PD. Methods: An extensive database search was conducted through PubMed, Web of Science, Embase, and the Cochrane Library to identify randomized controlled trials (RCTs) that investigated the impact of VR on patients with PD. Studies published before March 31, 2026, which met our inclusion and exclusion criteria, were included. A total of 13 RCTs involving 430 patients with PD were included. The Cochrane risk-of-bias tool was used to assess the risk of bias, indicating the included studies generally had a low risk of bias in randomization but a high or unclear risk concerning allocation concealment and blinding. Random-effects meta-analyses were performed using standardized mean differences (SMDs) with 95% CIs. Hartung-Knapp adjustments were applied, and prediction intervals (PIs) were calculated to assess the expected distribution of effects across future settings. The certainty of evidence was assessed using GRADE (Grading of Recommendations, Assessment, Development, and Evaluation). Results: In the meta-analysis, VR-based therapies were associated with statistically significant average improvements in global cognitive function (SMD=0.40, 95% CI 0.11-0.70; 95% PI 0.10-0.70; P =.01; I 2 =0%) and depressive symptoms (SMD=−0.77, 95% CI −1.42 to −0.12; 95% PI −1.82 to 0.27; P =.03; I 2 =31%). However, the PI for depression crossed the line of no effect, suggesting that this effect may vary across future settings. No significant average effects were observed for executive function (SMD=0.06, 95% CI −0.31 to 0.44; P =.66), memory (SMD=0.48, 95% CI −0.30 to 1.25; P =.15), attention (SMD=0.01, 95% CI −0.28 to 0.31; P =.94), or quality of life (QoL) outcomes (SMD=0.01, 95% CI −0.46 to 0.47; P =.97). Conclusions: The results suggest that VR-based therapies may be associated with improvements in global cognitive function and depressive symptoms in patients with PD, although evidence for executive function, attention, memory, and QoL remains inconclusive. This review provides an updated synthesis that differs from previous reviews by focusing on both global and domain-specific cognitive outcomes, as well as depressive symptoms and QoL, rather than mainly on motor outcomes. By incorporating recent RCTs and considering PIs, risk of bias, and GRADE certainty, this review offers a more cautious interpretation of the evidence. In practice, VR-based therapies may serve as an engaging adjunct to conventional rehabilitation, but larger and methodologically rigorous trials are needed before clinical recommendations can be made.